Editorial Board

Got the Flu? The Market Can Fix That.

Influenza vaccines are the best weapons we’ve got against a disease that each year kills as many as a half-million people, including 3,000 to 49,000 Americans. Yet this season’s worse-than-usual flu in the U.S. underscores the limitations of the existing vaccines.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.